DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Issue 05 · Volume 112 · May 2004 DOI: 10.1055/s-002-3351

Article

  • 225
    Herrmann, B. L.; Baumann, H.; Janssen, O. E.; Görges, R.; Schmid, K. W.; Mann, K.:

    Impact of Disease Activity on Thyroid Diseases in Patients with Acromegaly: Basal Evaluation and Follow-up

  • 231
    Bensing, S.; Rorsman, F.; Crock, P.; Sanjeevi, C.; Ericson, K.; Kämpe, O.; Brismar, K.; Hulting, A.-L.:

    No Evidence for Autoimmunity as a Major Cause of the Empty Sella Syndrome

  • 236
  • 241
    Winkler, K.; Weltzien, P.; Friedrich, I.; Schmitz, H.; Nickell, H.-H.; Hauck, P.; Hoffmann, M. M.; Baumstark, M. W.; Wieland, H.; März, W.:

    Qualitative Effect of Fenofibrate and Quantitative Effect of Atorvastatin on LDL Profile in Combined Hyperlipidemia with dense LDL

  • 248
    Shinde Urmila, A.; Sharma, G.; Xu Yan, J.; Dhalla Naranjan, S.; Goyal Ramesh, K.:

    Anti-Diabetic Activity and Mechanism of Action of Chromium Chloride

  • 253
    Stumvoll, M.; Fritsche, A.; t'Hart, L. M.; Machann, J.; Thamer, C.; Tschritter, O.; Van Haeften, T. W.; Jacob, S.; Dekker, J. M.; Maassen, J. A.; Machicao, F.; Schick, F.; Heine, R. J.; Häring, H.:

    The Gly482Ser Variant in the Peroxisome Proliferator-Activated Receptor γ Coactivator-1 is not Associated with Diabetes-Related Traits in Non-Diabetic German and Dutch Populations

  • 258
    Farkas, K.; Jermendy, G.; Herold, M.; Ruzicska, É; Sasvári, M.; Somogyi, A.:

    Impairment of the NO/cGMP Pathway in the Fasting and Postprandial State in Type 1 Diabetes Mellitus

  • 264
    Mayser, P.; Hensel, J.; Thoma, W.; Podobinska, M.; Geiger, M.; Ulbricht, H.; Haak, T.:

    Prevalence of Fungal Foot Infections in Patients with Diabetes Mellitus Type 1 - Underestimation of Moccasin-Type Tinea

  • 269
  • Case Report

  • 278